远程连接监测与常规面诊监测在类风湿关节炎管理中的随机对照试验
这项为期6个月的实用型随机对照试验纳入94例开始新DMARD治疗的中高疾病活动度RA患者,比较连接监测与常规监测。连接监测组在基线与6个月间的实际就诊次数显著低于常规监测组,临床与功能评分无差异,SF-12角色生理与角色情感维度生活质量更优。
要点
- 连接监测可减少RA患者实际就诊次数,同时维持疾病活动度的严密控制。
- 两组临床与功能评分无显著差异,连接监测组SF-12部分生活质量维度更优。
- 该电子健康方案为RA开始新治疗后的远程管理提供了随机对照证据。
核心结论
- 连接监测可减少RA开始新治疗患者的实际就诊次数,同时维持疾病活动度严密控制并改善生活质量。
研究设计与样本
- 为期6个月的实用型、随机、对照、前瞻性临床试验,纳入开始新DMARD治疗的中高疾病活动度RA患者,分为连接监测组与常规监测组。
主要发现
- 94例随机患者中89例完成研究,常规监测组44例、连接监测组45例。
- 基线与6个月间实际就诊总次数连接监测组显著低于常规监测组[0.42(0.58)vs 1.93(0.55);P<0.05]。
- 两组临床与功能评分无差异,连接监测组SF-12角色生理与角色情感维度生活质量更优。
关键数值与推荐
- 主要结局为基线与6个月间实际就诊次数,连接监测组0.42(0.58)次 vs 常规监测组1.93(0.55)次,P<0.05。
临床怎么用
- 对开始新DMARD治疗的中高疾病活动度RA患者,可考虑连接监测以减少面诊次数并维持疾病活动度控制。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In RA, telemedicine may allow tight control of disease activity while reducing hospital visits. We developed a smartphone application connected with a physician's interface to monitor RA patients. We aimed to assess the performance of this e-Health solution in comparison with routine practice in the management of patients with RA. METHODS: A six-month pragmatic, randomized, controlled, prospective, clinical trial was conducted in RA patients with high to moderate disease activity starting a new DMARD therapy. Two groups were established: 'connected monitoring' and 'conventional monitoring'. The primary outcome was the number of physical visits between baseline and six months. Secondary outcomes included adherence, satisfaction, changes in clinical, functional and health status scores (Short-Form 12). RESULTS: Of the 94 randomized patients, 89 completed study: 44 in the 'conventional monitoring' arm and 45 in the 'connected monitoring' arm. The total number of physical visits between required baseline and six-month visits was significantly lower in the 'connected monitoring' group [0.42 (0.58) vs 1.93 (0.55); P <0.05]. No differences between groups were observed in the clinical and functional scores. A better quality of life for Short-Form 12 subscores (Role-Physical and Role-Emotional) were found in the 'connected monitoring' group. CONCLUSION: Our results suggest that connected monitoring reduces the number of physical visits while maintaining a tight control of disease activity and improving quality of life in patients with RA starting a new treatment. TRIAL REGISTRATION: ClinicalTrials.gov, https://clinicaltrials.gov, NCT03005925.
引用
- Pers YM, Valsecchi V, Mura T, et al. A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis. Rheumatology (Oxford). 2021. PMID: 33020846. doi:10.1093/rheumatology/keaa462
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。